Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	modification-dependent protein binding	ANK2 ANK3 ATRX FAN1 BPTF ZZZ3 BRD4 PML	8.10e-05	206	135	8	GO:0140030
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	MYT1L TPR URI1 ATN1 ANK2 ANK3 SYNE1 HIPK2 FAN1 HIPK3 NCOR1 ZZZ3 ZNF451 BRD4 MDC1 TAF11 MLPH TRIM37 PML HR	1.04e-04	1160	135	20	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	MYT1L TPR URI1 ATN1 ANK2 SASH1 ANK3 SYNE1 HIPK2 FAN1 HIPK3 NCOR1 ZZZ3 ZNF451 BRD4 MDC1 TAF11 MLPH TRIM37 PML HR	3.02e-04	1356	135	21	GO:0060090
GeneOntologyMolecularFunction	transcription coregulator activity	MYT1L URI1 ATN1 HIPK2 HIPK3 NCOR1 ZNF451 BRD4 TAF11 TRIM37 PML HR	4.39e-04	562	135	12	GO:0003712
GeneOntologyBiologicalProcess	protein-DNA complex organization	BDP1 TPR ATRX HIPK2 CHD9 RIOX1 ATAD2 CREB1 HP1BP3 BPTF NCOR1 ZZZ3 BRD4 MDC1 TAF11 CABIN1 TRIM37 BRF2 PML HR	7.94e-06	999	135	20	GO:0071824
GeneOntologyBiologicalProcess	negative regulation of cell cycle process	TPR ATRX CEP192 TEX14 BRD4 MDC1 PINX1 CLSPN TRIM37 USP47 PML	2.69e-05	362	135	11	GO:0010948
GeneOntologyBiologicalProcess	protein localization to chromosome, telomeric region	ATRX CCT3 PINX1 PML	5.47e-05	32	135	4	GO:0070198
GeneOntologyBiologicalProcess	negative regulation of cell cycle	TPR ATRX CEP192 TEX14 TSC22D2 BRD4 MDC1 PINX1 CLSPN TRIM37 USP47 PML	5.54e-05	464	135	12	GO:0045786
GeneOntologyBiologicalProcess	post-translational protein modification	PSEN1 MARCHF10 SASH1 PARP8 RNF34 KIAA1586 DYSF BIRC6 HERC2P3 RNF157 ZNF451 PINX1 MINDY4 TRIM37 USP47 SENP7 RNF111 WDR24 PML	7.37e-05	1074	135	19	GO:0043687
GeneOntologyBiologicalProcess	negative regulation of chromosome organization	TPR ATRX CEP192 TEX14 PINX1 PML	7.40e-05	107	135	6	GO:2001251
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	PSEN1 MARCHF10 SASH1 RNF34 KIAA1586 DYSF BIRC6 HERC2P3 RNF157 ZNF451 PINX1 MINDY4 TRIM37 USP47 SENP7 RNF111 WDR24 PML	1.04e-04	1009	135	18	GO:0070647
GeneOntologyCellularComponent	sarcolemma	CACNB2 PSEN1 ANK2 ANK3 DTNA DTNBP1 DYSF AHNAK2	3.70e-05	190	137	8	GO:0042383
GeneOntologyCellularComponent	transcription factor TFIIIB complex	BDP1 BRF2	1.27e-04	3	137	2	GO:0000126
GeneOntologyCellularComponent	T-tubule	CACNB2 ANK2 ANK3 DYSF AHNAK2	1.72e-04	79	137	5	GO:0030315
GeneOntologyCellularComponent	PML body	ATRX HIPK2 HIPK3 ZNF451 RNF111 PML	1.76e-04	125	137	6	GO:0016605
GeneOntologyCellularComponent	costamere	ANK2 ANK3 AHNAK2	3.87e-04	22	137	3	GO:0043034
Domain	DUF3480	ZFYVE16 ZFYVE9	5.42e-05	2	138	2	PF11979
Domain	DUF3480	ZFYVE16 ZFYVE9	5.42e-05	2	138	2	IPR022557
Domain	Znf_FYVE_endofin	ZFYVE16 ZFYVE9	5.42e-05	2	138	2	IPR017165
Domain	Znf_FYVE	ZFYVE16 RNF34 ZFYVE9 MLPH	1.73e-04	38	138	4	IPR000306
Domain	ZF_FYVE	ZFYVE16 RNF34 ZFYVE9 MLPH	2.12e-04	40	138	4	PS50178
Domain	DUF846	TVP23B TVP23C	3.22e-04	4	138	2	PF05832
Domain	DUF846_euk	TVP23B TVP23C	3.22e-04	4	138	2	IPR008564
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BDP1 CACNB2 URI1 SGSM1 HIVEP2 ANK3 ATRX DTNA KIAA0232 FNBP4 HIPK2 CHD9 FRYL SRGAP2 CEP192 DENND2B NSRP1 TULP3 HP1BP3 HIPK3 BPTF COL18A1 GPR158 ZNF638 TVP23C MCTP2 MLPH BRMS1	9.85e-12	1489	141	28	28611215
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MRPS31 CCPG1 ANK2 ANK3 ATRX DTNA SYNE1 TTLL5 FNBP4 CEP192 ITPRID2 ZFC3H1 NSRP1 C2CD5 HP1BP3 NCBP3 COL18A1 DNAJC17 PTCD1 ZNF451 DDX18 TOR1AIP1 TPD52 PML NOL8	1.49e-09	1487	141	25	33957083
Pubmed	A human MAP kinase interactome.	TPR HIVEP2 ANK3 ABI3BP CCT3 SYNE1 KIAA0232 HIPK2 ITPRID2 CREB1 FAM13B HIPK3 ZNF451 ZHX1 RNF111	1.50e-09	486	141	15	20936779
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYT1L TTLL5 CHD9 FRYL ITPRID2 NCOR1 GPR158 TRIM37	2.66e-09	87	141	8	12465718
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	CCPG1 AFF2 ATN1 ANK3 ITPRID2 TEX14 TSC22D2 DTNBP1 TULP3 NCOR1 XIRP2 MDC1 CLSPN ZHX1	2.75e-09	430	141	14	35044719
Pubmed	Human transcription factor protein interaction networks.	MRPS31 SLK ATN1 ATRX CCT3 DTNA HIPK2 CEP192 CREB1 HP1BP3 BPTF NCOR1 FAT1 ZZZ3 ZKSCAN1 ZNF451 DDX18 MDC1 UBXN7 ZNF638 CABIN1 ZHX1 PML BRMS1	3.38e-09	1429	141	24	35140242
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TPR ATRX FNBP4 CREB1 NSRP1 HP1BP3 NCBP3 BPTF NCOR1 ZZZ3 ZNF451 BRD4 DDX18 MDC1 ZNF638 PINX1 TOR1AIP1 PML NOL8	1.21e-08	954	141	19	36373674
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	MYT1L TPR ZNF821 CACNB2 SAAL1 ANK3 ATRX HIPK2 FRYL SRGAP2 CEP192 TIAM2 C2CD5 COL18A1 PTCD1 VCAN ZNF638 KIF13A TRIM37 PML	1.71e-08	1084	141	20	11544199
Pubmed	Functional proteomics mapping of a human signaling pathway.	SASH1 ANK3 ATRX ZFYVE16 FNBP4 L1TD1 DENND2B PPP1R26 HIPK3 NCOR1 ZFYVE9 ZNF451 BRD4 KIF13A RNF111	2.04e-08	591	141	15	15231748
Pubmed	Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome.	ZFYVE16 TSC22D2 ATAD2 CREB1 MDC1 CLSPN	2.15e-08	43	141	6	34672947
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ZNF280D ATRX CHD9 ATAD2 HP1BP3 NCBP3 BPTF ZNF451 BRD4 MDC1 ZNF483 PINX1 CABIN1 ZHX1 SENP7	2.96e-08	608	141	15	36089195
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	ZNF821 CCPG1 ZGRF1 SRGAP2 DYSF BIRC6 HP1BP3 NCBP3 BPTF PWWP3B CABIN1 SENP7	3.33e-08	363	141	12	14691545
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BDP1 ATRX DTNA ZGRF1 HIPK2 CEP192 ITPRID2 CREB1 NCOR1 ZZZ3 ZNF451 CLSPN TRIM37 PML	1.35e-07	588	141	14	38580884
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	MYT1L ANK2 SYNE1 FRYL SRGAP2 DTNBP1 TIAM2 ZNF451	2.04e-07	151	141	8	17043677
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYT1L ZNF821 HIVEP2 ANK2 ANK3 ATRX SYNE1 TTLL5 CHD9 SRGAP2 ZFC3H1 FAN1 ZNF451 DDX18 OSBPL1A ANKRD36 CABIN1 TRIM37 USP47 RNF111	2.67e-07	1285	141	20	35914814
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	URI1 SAAL1 ANK3 CCT3 ZFYVE16 DTNA CEP192 ITPRID2 DTNBP1 BIRC6 TULP3 FAN1 NCOR1 ZFYVE9 PTPRZ1 ZNF638 PINX1 TPD52	2.75e-07	1049	141	18	27880917
Pubmed	A conserved acetylation switch enables pharmacological control of tubby-like protein stability.	MRPS31 CHD9 SRGAP2 BIRC6 TULP3 UBXN7 USP47 SENP7 PML	3.50e-07	223	141	9	33187986
Pubmed	Linking functions: an additional role for an intrinsically disordered linker domain in the transcriptional coactivator CBP.	ATRX HIPK3 ZNF451 ZHX1 RNF111	4.60e-07	38	141	5	28680062
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	ANK2 ZGRF1 FNBP4 L1TD1 HIPK2 RIOX1 TVP23B KIAA1586 HERC2P3 EVI5 COL18A1 FAT1 ZNF451 VCAN PWWP3B TOR1AIP1 ZHX1 TRIM37 RNF111	5.10e-07	1215	141	19	15146197
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR GCFC2 ATN1 ATRX FNBP4 ITPRID2 ATAD2 C2CD5 BPTF NCOR1 BRD4 MDC1 ZNF638 ZHX1 USP47	6.50e-07	774	141	15	15302935
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	NUP85 CCT3 ITPRID2 HP1BP3 NCOR1 MDC1 AHNAK2	7.44e-07	123	141	7	26912792
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	NUP85 SYNE1 ITPRID2 ATAD2 HP1BP3 NCBP3 DDX18 ZNF638 TOR1AIP1 PML	1.12e-06	332	141	10	25693804
Pubmed	Homeodomain-interacting protein kinase 1 modulates Daxx localization, phosphorylation, and transcriptional activity.	HIPK2 HIPK3 PML	1.29e-06	6	141	3	12529400
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	TPR SLK SRGAP2 CREB1 NSRP1 BPTF ZNF638 TOR1AIP1 PML AHNAK2	2.32e-06	360	141	10	33111431
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	ATRX BRD4 MDC1 UBXN7 ZNF638 PINX1 NOL8	2.57e-06	148	141	7	32538781
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HIVEP2 NUP85 FRYL SRGAP2 CEP192 DYSF BIRC6 TIAM2 C2CD2L PPP1R26 NCOR1 FAT1 BRD4 CABIN1 WDR24 AHNAK2 HR	2.66e-06	1105	141	17	35748872
Pubmed	The functional interactome landscape of the human histone deacetylase family.	TPR GCFC2 NUP85 CCT3 ATAD2 NCOR1 USP47 PML BRMS1	3.00e-06	289	141	9	23752268
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	MRPS31 AFF2 ANK3 CCT3 CEP192 BIRC6 HP1BP3 NCOR1 FAT1 DDX18 ZNF638 CLSPN TOR1AIP1 NOL8	3.63e-06	777	141	14	35844135
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	NUP85 ATRX CCT3 L1TD1 BIRC6 NCBP3 BPTF BRD4 ZNF638 PML BRMS1	3.64e-06	469	141	11	27634302
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	ATRX CHD9 ZFC3H1 ZNF451 BRD4 DDX18 PML NOL8	3.71e-06	222	141	8	37071664
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR SLK RIOK1 ANK2 ATRX CCT3 ZFYVE16 SRGAP2 NSRP1 HP1BP3 ZNF638 TOR1AIP1 PML AHNAK2 NOL8	6.43e-06	934	141	15	33916271
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SLK ZFYVE16 SYNE1 KIAA0232 CEP192 RNF157 C2CD2L TENM4 ZNF451 SENP7	6.83e-06	407	141	10	12693553
Pubmed	Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.	TPR ATRX HP1BP3 BRD4 MDC1	1.15e-05	72	141	5	31248990
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	ZNF280D HIPK2 ZZZ3 ZKSCAN1 ZNF451 PML	1.26e-05	125	141	6	32891193
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ATN1 L1TD1 CHD9 NSRP1 C2CD5 C2CD2L EDEM3 BPTF FAT1 ZZZ3 BRD4 DDX18 CLSPN TAF11 SENP7 PML	1.28e-05	1116	141	16	31753913
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	ATRX RIOX1 HP1BP3 COL18A1 DDX18 MDC1 CABIN1 PML NOL8	1.36e-05	349	141	9	25665578
Pubmed	Genome-wide map of nuclear protein degradation shows NCoR1 turnover as a key to mitochondrial gene regulation.	CREB1 NCOR1	1.63e-05	2	141	2	24315104
Pubmed	Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters.	BDP1 BRF2	1.63e-05	2	141	2	11040218
Pubmed	PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage.	HIPK2 PML	1.63e-05	2	141	2	19015637
Pubmed	Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.	ZFYVE16 ZFYVE9	1.63e-05	2	141	2	16775010
Pubmed	A new vertebrate SUMO enzyme family reveals insights into SUMO-chain assembly.	KIAA1586 ZNF451	1.63e-05	2	141	2	26524493
Pubmed	Arsenic-Induced Activation of the Homeodomain-Interacting Protein Kinase 2 (HIPK2) to cAMP-Response Element Binding Protein (CREB) Axis.	HIPK2 CREB1	1.63e-05	2	141	2	27884605
Pubmed	The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.	ANK2 ANK3	1.63e-05	2	141	2	11781319
Pubmed	Structural basis of diverse membrane target recognitions by ankyrins.	ANK2 ANK3	1.63e-05	2	141	2	25383926
Pubmed	Regulation of genotoxic stress response by homeodomain-interacting protein kinase 2 through phosphorylation of cyclic AMP response element-binding protein at serine 271.	HIPK2 CREB1	1.63e-05	2	141	2	20573984
Pubmed	Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.	PSEN1 PML	1.63e-05	2	141	2	23306558
Pubmed	Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly.	RIOK1 TTLL5 CEP192 CLSPN	1.72e-05	38	141	4	36674791
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	TPR CCT3 L1TD1 BPTF COL18A1 BRD4 MDC1	2.03e-05	203	141	7	22083510
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	TPR ATRX BPTF NCOR1 BRD4 MDC1 ZNF638 NOL8	2.17e-05	283	141	8	30585729
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	ANK2 DTNA SYNE1 DGKD DTNBP1 DYSF BIRC6 TULP3 NCOR1 XIRP2	3.78e-05	497	141	10	23414517
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYT1L SYNE1 KIAA0232 BIRC6 C2CD2L TENM4 GPR158	3.92e-05	225	141	7	12168954
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	TPR CCPG1 FNBP4 RIOX1 ZFC3H1 ATAD2 HP1BP3 NCOR1 DDX18 MDC1 ZNF638 TOR1AIP1 NOL8	4.37e-05	847	141	13	35850772
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	RIOK1 GCFC2 ZFYVE16 SRGAP2 BIRC6 C2CD2L EDEM3 ZNF451 MDC1 ZNF638 CLSPN TOR1AIP1	4.71e-05	733	141	12	34672954
Pubmed	Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX.	ATRX PML	4.88e-05	3	141	2	15252119
Pubmed	Molecular mechanisms of Bdp1 in TFIIIB assembly and RNA polymerase III transcription initiation.	BDP1 BRF2	4.88e-05	3	141	2	28743884
Pubmed	Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain.	DTNA DTNBP1	4.88e-05	3	141	2	11316798
Pubmed	The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease.	CREB1 PML	4.88e-05	3	141	2	11572863
Pubmed	The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells.	ANK2 ANK3	4.88e-05	3	141	2	15611082
Pubmed	BRD4 interacts with PML/RARα in acute promyelocytic leukemia.	BRD4 PML	4.88e-05	3	141	2	30552662
Pubmed	Haplotype-specific modulation of a SOX10/CREB response element at the Charcot-Marie-Tooth disease type 4C locus SH3TC2.	SH3TC2 CREB1	4.88e-05	3	141	2	24833716
Pubmed	Atrophin proteins interact with the Fat1 cadherin and regulate migration and orientation in vascular smooth muscle cells.	ATN1 FAT1	4.88e-05	3	141	2	19131340
Pubmed	Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling.	PSEN1 CREB1	4.88e-05	3	141	2	21784978
Pubmed	PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains.	HIPK2 PML	4.88e-05	3	141	2	12907596
Pubmed	SNP-specific array-based allele-specific expression analysis.	NLRP2 OSBPL1A	4.88e-05	3	141	2	18369178
Pubmed	PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX.	ATRX PML	4.88e-05	3	141	2	28341773
Pubmed	Human ankyrins and their contribution to disease biology: An update.	ANK2 ANK3	4.88e-05	3	141	2	33410423
Pubmed	Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres.	ATRX PML	4.88e-05	3	141	2	28358373
Pubmed	Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs.	HIPK2 HIPK3	4.88e-05	3	141	2	29793420
Pubmed	CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease.	PSEN1 CREB1	4.88e-05	3	141	2	21149712
Pubmed	Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue.	ANK2 ANK3	4.88e-05	3	141	2	34289389
Pubmed	Identification of Tpr and α-actinin-4 as two novel SLK-interacting proteins.	TPR SLK	4.88e-05	3	141	2	26094769
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	TPR PDE3A ZGRF1 SYNE1 FAM186A MDC1 KIF13A	5.02e-05	234	141	7	36243803
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP2 SASH1 KIAA0232 PARP8 FRYL SRGAP2 CEP192 ITPRID2 DENND2B BRD4 KIF13A PML AHNAK2	5.16e-05	861	141	13	36931259
Pubmed	Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.	ANK3 SYNE1 TENM4	6.03e-05	19	141	3	18711365
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	RIOK1 ATRX SYNE1 CEP192 BIRC6 FAM13B	6.64e-05	168	141	6	30631154
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	TPR ATRX CCT3 BPTF NCOR1 MDC1 ZNF638 AHNAK2	6.68e-05	332	141	8	32786267
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	SLK RIOK1 ZFYVE16 TTLL5 ATAD2 DNAJC17 ZNF638 PINX1 CABIN1 TOR1AIP1 TPD52	6.85e-05	645	141	11	25281560
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TPR ATRX CCT3 CHD9 HP1BP3 BPTF NCOR1 DNAJC17 ZNF451 BRD4 DDX18 MDC1 UBXN7 PML	6.87e-05	1014	141	14	32416067
Pubmed	Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex.	TPR ATRX HP1BP3 ZNF451 MDC1	7.44e-05	106	141	5	19394292
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ATRX FNBP4 ZFC3H1 CREB1 HP1BP3 BPTF NCOR1 ZZZ3 BRD4 DDX18 MDC1 ZNF638 CABIN1 TOR1AIP1 NOL8 BRMS1	7.53e-05	1294	141	16	30804502
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	BDP1 TPR CCPG1 NUP85 FAN1 BPTF TOR1AIP1	7.61e-05	250	141	7	33536335
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR CCT3 FRYL ATAD2 BIRC6 HP1BP3 BPTF DDX18 MDC1 ZNF638 USP47	7.64e-05	653	141	11	22586326
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MRPS31 ANK2 NUP85 ATRX ABI3BP CCT3 DTNA SYNE1 PARP8 DNAH2 ZFC3H1 TEX14 HP1BP3 BPTF NCOR1 FAM186A MLPH	7.94e-05	1442	141	17	35575683
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	NUP85 HP1BP3 NCBP3 BPTF NCOR1 MDC1 UBXN7 ZNF638	8.04e-05	341	141	8	32971831
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR SLK ANK3 FNBP4 BPTF NCOR1 ZZZ3 BRD4 MDC1 TPD52	8.63e-05	549	141	10	38280479
Pubmed	Estrogenic induction of spermatogenesis in the hypogonadal mouse.	HIPK2 HIPK3	9.74e-05	4	141	2	10919273
Pubmed	Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.	HIPK2 PML	9.74e-05	4	141	2	21192925
Pubmed	USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638.	CREB1 ZNF638	9.74e-05	4	141	2	33040080
Pubmed	A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.	MDC1 CLSPN	9.74e-05	4	141	2	16901786
Pubmed	Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK).	HIPK2 HIPK3	9.74e-05	4	141	2	25630557
Pubmed	The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response.	NLRP2 MDC1	9.74e-05	4	141	2	23964092
Pubmed	AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.	DYSF AHNAK2	9.74e-05	4	141	2	17185750
Pubmed	SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death.	HIPK2 PML	9.74e-05	4	141	2	20188669
Pubmed	Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation.	HIPK2 HIPK3	9.74e-05	4	141	2	34785661
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	ZNF821 ATN1 ATRX CCT3 KIAA0232 TTLL5 DGKD FRYL ITPRID2 PML	1.02e-04	560	141	10	21653829
Pubmed	A genome-wide association study identifies protein quantitative trait loci (pQTLs).	CACNB2 SASH1 DYSF OSBPL1A	1.13e-04	61	141	4	18464913
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	MYT1L URI1 ZNF280D ATAD2 CERS5 BPTF NCOR1 ZKSCAN1 ZNF451 BRD4 ZNF638 PML	1.18e-04	808	141	12	20412781
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	CCPG1 GCFC2 SRGAP2 ACAD10 PPP1R26 NCOR1 FAT1 ZKSCAN1 ZNF451 ZNF483 NOL8	1.22e-04	689	141	11	36543142
Pubmed	A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.	TPR HP1BP3 MDC1 TOR1AIP1 PML	1.39e-04	121	141	5	22412018
Pubmed	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.	CACNB2 ANK3 SYNE1 TENM4	1.45e-04	65	141	4	23453885
Interaction	CSNK2A1 interactions	MRPS31 BDP1 RIOK1 GCFC2 ATN1 ATRX CCT3 FNBP4 SRGAP2 ZFC3H1 ANKRD36C ATAD2 BIRC6 CREB1 HP1BP3 NCOR1 BRD4 MDC1 ANKRD36 TOR1AIP1 ZHX1 RNF111 PML BRMS1	4.23e-08	956	140	24	int:CSNK2A1
Interaction	H3C1 interactions	TPR RIOK1 ANK2 ZNF280D ANK3 ATRX SYNE1 DNAH2 ATAD2 CREB1 NSRP1 HP1BP3 BPTF NCOR1 DNAJC17 XIRP2 BRD4 DDX18 MDC1 ZNF638 PINX1 PWWP3B CABIN1	6.23e-08	901	140	23	int:H3C1
Interaction	NUP43 interactions	ATN1 NUP85 ZNF280D CCT3 CHD9 ITPRID2 ZFC3H1 ATAD2 HP1BP3 NCBP3 BPTF NCOR1 ZZZ3 DDX18 MDC1 UBXN7 ZHX1 AHNAK2	3.47e-07	625	140	18	int:NUP43
Interaction	DNAJC17 interactions	GCFC2 FNBP4 ZFC3H1 NSRP1 NCBP3 DNAJC17 BRD4 PML NOL8	4.07e-07	134	140	9	int:DNAJC17
Interaction	CBX3 interactions	ZNF280D ATRX HIPK2 CHD9 ATAD2 NSRP1 HP1BP3 NCOR1 ZNF451 BRD4 MDC1 UBXN7 ZNF483 PINX1 CLSPN TOR1AIP1 SENP7 NOL8	5.62e-07	646	140	18	int:CBX3
Interaction	SUMO2 interactions	TPR RIOK1 ATRX CCT3 HIPK2 HP1BP3 BPTF NCOR1 ZNF451 BRD4 MDC1 ZNF638 ZHX1 SENP7 RNF111 PML AHNAK2	7.68e-07	591	140	17	int:SUMO2
Interaction	MAP1LC3C interactions	CCPG1 ANK2 ANK3 CCT3 BIRC6 NCOR1	1.08e-05	72	140	6	int:MAP1LC3C
Interaction	H2BC8 interactions	RIOK1 ZNF280D ATRX ATAD2 NSRP1 HP1BP3 NCBP3 BPTF DNAJC17 BRD4 MDC1 UBXN7 PINX1 TOR1AIP1 TPD52	1.18e-05	576	140	15	int:H2BC8
Interaction	UBN1 interactions	BDP1 BRD4 CABIN1 TRIM37 BRF2 PML	1.60e-05	77	140	6	int:UBN1
Interaction	H3-3A interactions	RIOK1 ZNF280D ATRX CHD9 ATAD2 HP1BP3 NCBP3 BPTF ZNF451 BRD4 MDC1 ZNF483 PINX1 CABIN1 ZHX1 SENP7 PML	1.79e-05	749	140	17	int:H3-3A
Interaction	FHL2 interactions	NIBAN1 SOX30 HIPK2 CREB1 NCOR1 ZZZ3 ZFYVE9 ZNF638 TRIM37 RNF111 PML BRMS1	2.13e-05	396	140	12	int:FHL2
Interaction	NUP50 interactions	NUP85 FNBP4 NCOR1 ZNF451 BRD4 UBXN7 CLSPN TOR1AIP1 USP47 PML NOL8	2.69e-05	341	140	11	int:NUP50
Interaction	FGF12 interactions	ANK3 FNBP4 CHD9 C2CD5 MDC1 USP47	3.21e-05	87	140	6	int:FGF12
Interaction	SNRNP40 interactions	GCFC2 ATN1 ZNF280D ZFC3H1 ATAD2 NCOR1 DNAJC17 ZNF451 BRD4 DDX18 MDC1 UBXN7 PINX1 PML NOL8	3.79e-05	637	140	15	int:SNRNP40
Interaction	CENPA interactions	ATRX ATAD2 HP1BP3 NCBP3 BPTF ZNF451 DDX18 UBXN7 PINX1 TOR1AIP1 NOL8	6.68e-05	377	140	11	int:CENPA
Interaction	HDAC1 interactions	TPR RIOK1 ATRX CCT3 ZFYVE16 ZGRF1 BIRC6 CREB1 RNF157 BPTF NCOR1 ZZZ3 BRD4 ZNF638 CABIN1 ZHX1 USP47 PML HR BRMS1	8.21e-05	1108	140	20	int:HDAC1
Interaction	SIAH2 interactions	ATN1 HIPK2 HIPK3 NCOR1 SENP7 PML	8.76e-05	104	140	6	int:SIAH2
Interaction	H2BC21 interactions	RIOK1 ZNF280D ATRX DNAH2 FNBP4 HIPK2 ATAD2 HP1BP3 C2CD2L BPTF ZZZ3 BRD4 MDC1 ZNF638 SENP7	1.02e-04	696	140	15	int:H2BC21
Interaction	ZMYM2 interactions	ZNF280D ATRX HIPK2 TSC22D2 CREB1 ZZZ3 ZKSCAN1 ZNF451 PML	1.19e-04	271	140	9	int:ZMYM2
Interaction	AGBL4 interactions	RIOK1 CCT3 TTLL5 CEP192 CLSPN	1.27e-04	70	140	5	int:AGBL4
Interaction	TERF2IP interactions	NSRP1 HP1BP3 BPTF NCOR1 ZZZ3 BRD4 MDC1 UBXN7 ZNF638 PINX1 CLSPN TOR1AIP1 PML	1.28e-04	552	140	13	int:TERF2IP
Interaction	IFI16 interactions	TPR RIOK1 NUP85 SYNE1 ITPRID2 ATAD2 HP1BP3 NCBP3 BRD4 DDX18 MDC1 ZNF638 PINX1 TOR1AIP1 PML	1.36e-04	714	140	15	int:IFI16
Interaction	SLF2 interactions	GCFC2 ATRX ZNF451 PML	1.37e-04	38	140	4	int:SLF2
Interaction	TULP3 interactions	MRPS31 CHD9 SRGAP2 BIRC6 TULP3 NCOR1 UBXN7 USP47 SENP7 PML	1.56e-04	346	140	10	int:TULP3
Interaction	SLX4 interactions	ATRX CCT3 CHD9 ZFC3H1 NCOR1 ZZZ3 ZNF451 BRD4 DDX18 MDC1 CLSPN PML NOL8	1.81e-04	572	140	13	int:SLX4
Cytoband	1q25	TPR NIBAN1 EDEM3	7.00e-05	26	141	3	1q25
Cytoband	3q12	ABI3BP SENP7	9.31e-05	5	141	2	3q12
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SLK URI1 HIVEP2 SASH1 ATRX ZFYVE16 CHD9 FRYL SRGAP2 TSC22D2 CREB1 DENND2B C2CD5 EVI5 BPTF FAT1 ZZZ3 ZFYVE9 ZNF451 UBXN7 ZNF638 TRIM37	9.07e-10	856	139	22	M4500
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	HIVEP2 ATRX KIAA0232 CHD9 FRYL ZFC3H1 BPTF FAT1 ZZZ3 ZNF451 MDC1 ZNF638 TAF11	8.01e-09	300	139	13	M8702
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	SLK HIVEP2 ATRX CHD9 FRYL SRGAP2 CREB1 C2CD5 EVI5 BPTF FAT1 ZZZ3 ZFYVE9 ZNF638 TRIM37	2.92e-08	466	139	15	M13522
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	MRPS31 BDP1 SLK L1TD1 HIPK2 CEP192 ATAD2 CREB1 FAM13B NSRP1 BPTF ZZZ3 OSBPL1A ZNF638 ZHX1 USP47 TPD52	7.77e-08	656	139	17	M18979
Coexpression	CHEN_HOXA5_TARGETS_9HR_UP	ZNF280D SOX30 FNBP4 CHD9 TSC22D2 FAM13B ZZZ3 ZNF451 RNF111	3.13e-06	223	139	9	M17621
Coexpression	GSE369_IFNG_KO_VS_WT_LIVER_UP	ATRX GANC ZFC3H1 CREB1 FAM13B HIPK3 CERS5 RNF111	1.15e-05	199	139	8	M5970
Coexpression	LIU_BREAST_CANCER	CHD9 FAN1 NCOR1 MLPH	2.43e-05	32	139	4	M16584
Coexpression	RAMASWAMY_METASTASIS_UP	URI1 SRGAP2 ZFC3H1 BPTF TRIM37	2.69e-05	66	139	5	M6698
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	HIPK2 CEP192 C2CD2L EVI5 BPTF PTCD1 BRD4 VCAN TOR1AIP1 NOL8	3.54e-05	378	139	10	M41174
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	BDP1 TPR NIBAN1 SLK URI1 HIVEP2 ATRX SYNE1 PARP8 FNBP4 FRYL ZFC3H1 BIRC6 CREB1 FAM13B BPTF NCOR1 ZNF638 TOR1AIP1 USP47 SENP7	3.99e-05	1492	139	21	M40023
Coexpression	RODRIGUES_THYROID_CARCINOMA_DN	HIVEP2 ANK3 HIPK2 TSC22D2 UBXN7	6.04e-05	78	139	5	M9814
Coexpression	BILD_CTNNB1_ONCOGENIC_SIGNATURE	ATRX HIPK2 CHD9 FRYL VCAN	6.42e-05	79	139	5	M7102
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	MYT1L BDP1 CCPG1 AFF2 ANK2 ANK3 ATRX RUNDC3B RNF157 C2CD5 GPR158 VCAN TVP23C CREG2 ANKRD36 KIF13A AHNAK2	8.10e-05	1106	139	17	M39071
Coexpression	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	ANK2 FRYL TEX14 TSC22D2 FAN1 COL18A1 MDC1 TRIM37 RNF111	8.75e-05	340	139	9	M2012
Coexpression	GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP	NIBAN1 CCPG1 HIPK2 CREB1 HIPK3 PINX1 ZHX1	9.59e-05	199	139	7	M3217
Coexpression	GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP	BDP1 ZFC3H1 TEX14 CREB1 HP1BP3 TOR1AIP1 USP47	9.59e-05	199	139	7	M3046
Coexpression	GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN	ZNF821 HIVEP2 CHD9 DTNBP1 ATAD2 NCBP3 HIPK3	9.89e-05	200	139	7	M6393
Coexpression	GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN	URI1 RIOK1 ATRX TVP23B C2CD5 CERS5 EDEM3	9.89e-05	200	139	7	M8656
Coexpression	GSE3982_MAST_CELL_VS_TH2_DN	TPR NUP85 FRYL ATAD2 HP1BP3 DDX18 TPD52	9.89e-05	200	139	7	M5456
Coexpression	GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN	CCPG1 ZNF280D NCBP3 C2CD2L ZNF451 TPD52 BRMS1	9.89e-05	200	139	7	M3933
Coexpression	MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS	BDP1 TPR ATRX BPTF ZKSCAN1	1.19e-04	90	139	5	M39250
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	CHD9 FRYL FAT1 ZZZ3 ZNF451 ZNF638	1.27e-04	145	139	6	M1810
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	CACNB2 SLK HIVEP2 SRGAP2 FAT1 ANKRD36 KIF13A	1.42e-04	212	139	7	M39221
Coexpression	BROWNE_HCMV_INFECTION_14HR_DN	MRPS31 DTNA SYNE1 HIPK2 DENND2B TULP3 ZKSCAN1 AHNAK2	1.64e-04	290	139	8	M13251
Coexpression	NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN	ATN1 PSEN1 LRRC37A3 HIPK2 EVI5 DDX18 TPD52 HR	1.80e-04	294	139	8	M41112
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	BDP1 TPR CACNB2 URI1 SAAL1 GCFC2 ANK2 ZNF280D ATRX DTNA ZGRF1 HIPK2 CHD9 CEP192 ATAD2 NSRP1 EVI5 BPTF PTPRZ1 BRD4 MDC1 PINX1 PWWP3B CLSPN TRIM37 NOL8	1.54e-07	1257	139	26	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	BDP1 TPR CACNB2 URI1 SAAL1 GCFC2 AFF2 ANK2 ZNF280D ATRX DTNA ZGRF1 HIPK2 CHD9 CEP192 ATAD2 NSRP1 EVI5 BPTF PTPRZ1 BRD4 MDC1 PINX1 PWWP3B CLSPN TRIM37 NOL8	7.74e-07	1459	139	27	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	BDP1 CCPG1 SLK URI1 ZNF280D ATRX ZGRF1 DNAH2 CHD9 NSRP1 RNF157 BPTF ZZZ3 ZFYVE9 CREG2 CLSPN	3.77e-06	629	139	16	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	BDP1 TPR SLK URI1 RIOK1 ZNF280D ATRX ZGRF1 CHD9 NSRP1 BPTF ZZZ3 ZFYVE9 MDC1 ZHX1	4.53e-06	564	139	15	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	TPR ANK3 HIPK2 DGKD BIRC6 HIPK3 TENM4 ZKSCAN1 BRD4 VCAN UBXN7 KIF13A	8.96e-06	385	139	12	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	TPR CACNB2 SGSM1 GCFC2 AFF2 ANK2 ZNF280D ATRX GANC DTNA PARP8 HIPK2 CHD9 FRYL ZFC3H1 BPTF FAT1 PTPRZ1 BRD4 PWWP3B CLSPN TRIM37 SENP7	2.76e-05	1370	139	23	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	BDP1 TPR ZNF280D DNAH2 CEP192 NSRP1 ZNF638 CLSPN	3.16e-05	186	139	8	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	TPR PDE3A ANK3 HIPK2 SRGAP2 BIRC6 HIPK3 ZKSCAN1 VCAN UBXN7	4.07e-05	312	139	10	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	ANK3 ATRX FNBP4 HIPK2 DGKD BIRC6 NCBP3 HIPK3 BPTF NCOR1 ZKSCAN1	4.12e-05	379	139	11	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	TPR PDE3A ANK3 HIPK2 HIPK3 ZKSCAN1 VCAN	5.73e-05	149	139	7	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	BDP1 CCPG1 ATRX CEP192 DYSF NSRP1 ZFYVE9 MDC1 ZNF638 PINX1 CLSPN NOL8	6.20e-05	469	139	12	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	SLK URI1 ZNF280D ATRX ZGRF1 CHD9 NSRP1 BPTF ZFYVE9 PTPRZ1 MDC1 CLSPN TRIM37	1.49e-04	595	139	13	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	TPR SAAL1 AFF2 ZNF280D ANK3 ATRX CCT3 HIPK2 CHD9 CEP192 DTNBP1 ATAD2 NSRP1 EVI5 BRD4 VCAN PINX1 PWWP3B CLSPN NOL8	1.70e-04	1241	139	20	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4	NIBAN1 HIVEP2 AFF2 ZNF280D ATRX ABI3BP ZFYVE16 DNAH2 FNBP4 RNF157 BPTF TENM4 PTPRZ1 VCAN PWWP3B TAF11 MLPH SENP7 HR	1.79e-04	1148	139	19	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	BDP1 CACNB2 GCFC2 ATN1 ZNF280D ATRX TTLL5 HIPK2 NSRP1 C2CD5 HP1BP3 CERS5 EVI5 EDEM3 CLSPN	1.86e-04	780	139	15	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000	RUNDC3B TTLL5 L1TD1 CEP192 CCDC160 TEX14 ATAD2 C2CD5 ZNF451 DDX18 CLSPN TRIM37 TPD52 PML NOL8	1.89e-04	781	139	15	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	TPR CACNB2 CCPG1 URI1 SAAL1 ZNF280D ATRX DTNA HIPK2 CHD9 CEP192 TSC22D2 ATAD2 EVI5 BRD4 VCAN ZNF638 PWWP3B CLSPN SENP7	1.91e-04	1252	139	20	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	NIBAN1 CCPG1 HIVEP2 AFF2 ANK2 ZNF280D ATRX ABI3BP ZFYVE16 PARP8 DNAH2 CHD9 EVI5 FAT1 TENM4 PTPRZ1 VCAN PWWP3B SENP7	2.18e-04	1166	139	19	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	BDP1 TPR NIBAN1 AFF2 ZNF280D ABI3BP DTNA DNAH2 SRGAP2 CEP192 NSRP1 RNF157 ZNF638 CREG2 PWWP3B CLSPN SENP7	2.27e-04	978	139	17	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	ANK3 ATRX FNBP4 HIPK2 DGKD CCDC160 ATAD2 BIRC6 NCBP3 HIPK3 BPTF NCOR1 ZKSCAN1 MCTP2 ZHX1	2.29e-04	795	139	15	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500	RUNDC3B L1TD1 CEP192 TEX14 ATAD2 C2CD5 ZNF451 CLSPN TRIM37 NOL8	2.39e-04	387	139	10	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	SH3TC2 ATRX CCT3 DTNA FNBP4 L1TD1 CHD9 TEX14 BIRC6 RNF157 TENM4 ZNF451 ZNF638 SENP7 NOL8	2.65e-04	806	139	15	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#1	SH3TC2 RIOK1 NUP85 ZGRF1 RNF34 CHD9 RIOX1 CEP192 ACAD10 KIAA1586 BIRC6 NCBP3 EDEM3 DNAJC17 CLSPN SENP7 BRF2	2.72e-04	993	139	17	ratio_EB-blastocyst_vs_EB-fibro_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500	PDE3A ANK3 HIPK3 ZKSCAN1 VCAN UBXN7 DMP1	2.95e-04	194	139	7	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	RUNDC3B ZGRF1 TTLL5 L1TD1 DGKD CEP192 TEX14 ATAD2 ZFYVE9 ZNF451 MDC1 ZNF483 CLSPN TRIM37 NOL8	3.18e-04	820	139	15	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5	BDP1 TPR NIBAN1 ZNF280D ABI3BP SRGAP2 CEP192 ZNF638 PWWP3B	3.39e-04	331	139	9	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500	RUNDC3B L1TD1 CEP192 TEX14 ATAD2 C2CD5 ZNF451 CLSPN TRIM37 NOL8	3.49e-04	406	139	10	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3	BDP1 TPR NIBAN1 PDE3A AFF2 ZNF280D ABI3BP SYNE1 DNAH2 SRGAP2 CEP192 ZNF638 CREG2 PWWP3B CLSPN	3.80e-04	834	139	15	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000	ANK3 ATRX HIPK2 ATAD2 ZKSCAN1 VCAN	4.04e-04	146	139	6	gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	AFF2 DTNA DNAH2 NSRP1 RNF157 CREG2 CLSPN SENP7	4.23e-04	271	139	8	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500	ANK3 HIPK2 BIRC6 HIPK3 ZKSCAN1 BRD4 VCAN	4.61e-04	209	139	7	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_500	CEP192 TEX14 ZNF451 TRIM37 NOL8	5.35e-04	101	139	5	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	BDP1 TPR SLK URI1 AFF2 ZNF280D ATRX SYNE1 NSRP1 CLSPN	5.66e-04	432	139	10	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000	HIVEP2 ANK2 ABI3BP NCOR1 ZNF451 OSBPL1A KIF13A SENP7	6.32e-04	288	139	8	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	RUNDC3B ZGRF1 TTLL5 CEP192 ATAD2 ZNF451 MDC1 CLSPN TRIM37	6.34e-04	361	139	9	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500	SH3TC2 AFF2 DTNA RNF34 DENND2B COL18A1 FAT1 VCAN KCNT1 TPD52	6.64e-04	441	139	10	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	BDP1 AFF2 ZNF280D ATRX HIPK2 NSRP1 EVI5 CLSPN	6.76e-04	291	139	8	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	BDP1 PDE3A SGSM1 AFF2 MARCHF10 ZNF280D ATRX GANC HIPK2 NSRP1 HP1BP3 EVI5 CLSPN KIF13A SENP7 PML	7.32e-04	985	139	16	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	TPR PDE3A ANK3 ATRX HIPK3 ZKSCAN1 VCAN UBXN7 DMP1	7.40e-04	369	139	9	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000	RUNDC3B ZGRF1 L1TD1 CEP192 CCDC160 TEX14 ATAD2 C2CD5 ZNF451 DDX18 CLSPN TRIM37 TPD52 NOL8	7.72e-04	799	139	14	gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	TPR NIBAN1 PDE3A SAAL1 ANK3 L1TD1 HIPK2 SRGAP2 BIRC6 HIPK3 TENM4 ZKSCAN1 VCAN UBXN7	8.39e-04	806	139	14	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	CCT3 RUNDC3B L1TD1 CEP192 TEX14 ATAD2 NSRP1 C2CD5 ZNF451 DDX18 CLSPN CABIN1 TRIM37 NOL8	8.80e-04	810	139	14	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	ZNF280D ATRX CCT3 FNBP4 L1TD1 CHD9 BIRC6 RNF157 NCBP3 TENM4 PTPRZ1 ZNF451 SENP7 BRMS1	9.34e-04	815	139	14	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	TPR ANK2 ANK3 HIPK2 DGKD BIRC6 HIPK3 TENM4 ZKSCAN1 PTPRZ1 BRD4 VCAN UBXN7 KIF13A	9.67e-04	818	139	14	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 ANK3 ATRX SYNE1 PARP8 FRYL ZFC3H1 ANKRD36C BPTF ZNF451 ANKRD36 MCTP2	1.78e-12	199	140	12	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	BDP1 ATRX ZFC3H1 ANKRD36C NSRP1 DDX18 ZNF638 ANKRD36 CLSPN NOL8	7.21e-10	197	140	10	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	MYT1L ANK2 ATRX CHD9 ANKRD36C TIAM2 BPTF ZKSCAN1 VCAN ANKRD36	7.58e-10	198	140	10	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ANK3 ATRX FNBP4 ZFC3H1 ANKRD36C RNF157 BPTF ZNF638 ANKRD36	1.20e-08	195	140	9	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	CACNB2 NIBAN1 PDE3A ANK2 ANK3 DGKD FAT1 XIRP2	1.62e-07	190	140	8	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	ANKRD36C HP1BP3 BPTF NCOR1 ZKSCAN1 BRD4 ANKRD36 AHNAK2	1.75e-07	192	140	8	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	CACNB2 NIBAN1 PDE3A ANK2 ANK3 DTNA DGKD XIRP2	1.83e-07	193	140	8	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TPR ATRX HIPK2 NSRP1 BPTF BRD4 OSBPL1A USP47	2.31e-07	199	140	8	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MARCHF10 KIAA0232 TIAM2 ZNF451 MDC1 MINDY4 KIF13A	7.00e-07	158	140	7	1d78578dc1f8ba43dacdccae1082c0b9d749f64d
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR PDE3A AFF2 ATRX CHD9 XIRP2 ZNF638	1.44e-06	176	140	7	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX CHD9 BIRC6 HP1BP3 NCOR1 ZNF638	1.94e-06	184	140	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 ANK3 ABI3BP DTNA TENM4 MCTP2 AHNAK2	2.01e-06	185	140	7	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRPS31 CACNB2 ANK3 ABI3BP TTLL5 ZFYVE9 KIF13A	2.24e-06	188	140	7	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRPS31 CACNB2 ANK3 ABI3BP TTLL5 ZFYVE9 KIF13A	2.24e-06	188	140	7	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRPS31 CACNB2 ANK3 ABI3BP TTLL5 ZFYVE9 KIF13A	2.24e-06	188	140	7	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 NIBAN1 PDE3A ABI3BP DTNA TENM4 MCTP2	2.32e-06	189	140	7	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	HIVEP2 FAN1 EDEM3 ZFYVE9 VCAN SENP7	2.45e-06	122	140	6	a2f343962069253a08faa80fd70723b8488a99ec
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX CHD9 HP1BP3 NCBP3 NCOR1 ZKSCAN1	2.48e-06	191	140	7	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX CHD9 HP1BP3 NCBP3 NCOR1 ZKSCAN1	2.48e-06	191	140	7	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX CHD9 HP1BP3 NCBP3 NCOR1 ZKSCAN1	2.48e-06	191	140	7	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	CACNB2 NIBAN1 PDE3A ANK2 ANK3 DTNA XIRP2	2.85e-06	195	140	7	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TPR ATRX NSRP1 BPTF NCOR1 BRD4 ANKRD36	3.26e-06	199	140	7	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 TPR ATRX FRYL ZFC3H1 BIRC6 BPTF	3.37e-06	200	140	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CCT3 RIOX1 ACAD10 TSC22D2 COL18A1 DNAJC17	1.39e-05	165	140	6	3c8baed838eccb6e720bacb7458f087647dc1222
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	FAN1 EDEM3 ZFYVE9 VCAN SENP7 NOL8	1.44e-05	166	140	6	f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYT1L NIBAN1 PDE3A DGKD DENND2B MCTP2	1.64e-05	170	140	6	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF2 ZGRF1 PTPRZ1 VCAN CREG2 PWWP3B	2.20e-05	179	140	6	7c8a2fa1326c73dc9e774df645b572864fd97133
ToppCell	P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NIBAN1 ANK3 COL18A1 PTPRZ1 VCAN MLPH	2.27e-05	180	140	6	1e819c5c87704ec6535dfeaae56561895e239d07
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNB2 NIBAN1 PDE3A ANK2 DTNA XIRP2	2.34e-05	181	140	6	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NIBAN1 PDE3A ANK2 DTNA DGKD XIRP2	2.49e-05	183	140	6	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SASH1 HIPK2 DYSF PINX1 KIF13A PML	2.49e-05	183	140	6	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	CACNB2 PDE3A ANK2 ANK3 DTNA XIRP2	2.57e-05	184	140	6	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNB2 NIBAN1 PDE3A ANK2 DTNA XIRP2	2.57e-05	184	140	6	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PDE3A ANK2 ABI3BP DTNA TENM4 PWWP3B	2.65e-05	185	140	6	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNB2 NIBAN1 PDE3A ANK2 DTNA XIRP2	2.65e-05	185	140	6	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	ANK3 CHD9 ANKRD36C NCBP3 BPTF NCOR1	2.65e-05	185	140	6	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	CACNB2 PDE3A ANK2 ANK3 DTNA XIRP2	2.65e-05	185	140	6	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	CACNB2 NIBAN1 ANK2 ANK3 DTNA DYSF	2.90e-05	188	140	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 PDE3A ABI3BP DTNA SYNE1 FAT1	2.99e-05	189	140	6	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	CACNB2 NIBAN1 PDE3A ANK2 ANK3 XIRP2	2.99e-05	189	140	6	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF2 ANK2 ABI3BP XIRP2 VCAN OSBPL1A	3.08e-05	190	140	6	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ZGRF1 CEP192 ATAD2 HP1BP3 MDC1 CLSPN	3.08e-05	190	140	6	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	CACNB2 NIBAN1 PDE3A ANK2 ANK3 DTNA	3.08e-05	190	140	6	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 PDE3A ANK2 ABI3BP DTNA VCAN	3.17e-05	191	140	6	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	CACNB2 NIBAN1 PDE3A ANK2 ANK3 DTNA	3.17e-05	191	140	6	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	CACNB2 NIBAN1 ANK2 ANK3 DTNA DYSF	3.17e-05	191	140	6	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	FRYL ANKRD36C BIRC6 ZZZ3 MCTP2 RNF111	3.17e-05	191	140	6	9454f642c3621370fa23640b631301346b300950
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 PDE3A ABI3BP DTNA SYNE1 FAT1	3.17e-05	191	140	6	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 PDE3A ANK2 DTNA SYNE1 FAT1	3.17e-05	191	140	6	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ATRX ZFYVE16 FRYL BIRC6 CREB1 BPTF	3.36e-05	193	140	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SASH1 RUNDC3B HIPK2 SRGAP2 DYSF KIF13A	3.36e-05	193	140	6	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MARCHF10 ANK3 DNAH2 DENND2B PTPRZ1 AHNAK2	3.36e-05	193	140	6	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SASH1 RUNDC3B HIPK2 SRGAP2 DYSF KIF13A	3.36e-05	193	140	6	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 PDE3A ANK2 ABI3BP DTNA SYNE1	3.46e-05	194	140	6	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 PDE3A ANK2 ABI3BP DTNA SYNE1	3.46e-05	194	140	6	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	CACNB2 NIBAN1 PDE3A ANK2 ANK3 DTNA	3.56e-05	195	140	6	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	critical-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NIBAN1 ITPRID2 HP1BP3 PTPRZ1 MLPH TPD52	3.66e-05	196	140	6	dbf14f5851c2b779a8b35e820c4584ea9096e49d
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ANK3 SYNE1 FRYL ZFC3H1 ANKRD36C ANKRD36	3.76e-05	197	140	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-midbrain/hindbrain_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	MYT1L ANK2 ANK3 RUNDC3B CREG2 TPD52	3.76e-05	197	140	6	c7078f6fcf27319ba8c5ebe700bcae7f1e7e39c1
ToppCell	Mild\|World / Condition, Lineage, Cell class and cell subclass	BDP1 TPR ATRX PARP8 NCOR1 TOR1AIP1	3.76e-05	197	140	6	476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 PDE3A ABI3BP TENM4 VCAN HR	3.76e-05	197	140	6	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TPR URI1 ATRX SYNE1 ZNF638 ANKRD36	3.87e-05	198	140	6	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NIBAN1 ANK3 PTPRZ1 PWWP3B MLPH TPD52	3.87e-05	198	140	6	5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NIBAN1 ANK3 PTPRZ1 PWWP3B MLPH TPD52	3.87e-05	198	140	6	6ba5e5970109a04ed968bac7ff099ae250c579dc
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2\|World / Primary Cells by Cluster	MYT1L BDP1 HIVEP2 ANK2 ANK3 RUNDC3B	3.98e-05	199	140	6	f09b40245d3d826275bbe5f508dedccc75a911bd
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV\|World / Primary Cells by Cluster	MYT1L BDP1 HIVEP2 ANK2 ANK3 RUNDC3B	3.98e-05	199	140	6	e45448ec4db8875c8aaa9aad109a10e2905a4226
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	ATRX HIPK2 NSRP1 BPTF BRD4 OSBPL1A	3.98e-05	199	140	6	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	Mild/Remission-B_memory-3\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ZNF821 NIBAN1 ANK3 HIPK2 TIAM2 COL18A1	3.98e-05	199	140	6	493d043beef70b60338cc199db82592cdc6e635d
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NIBAN1 CHD9 ITPRID2 HP1BP3 PTPRZ1 TPD52	3.98e-05	199	140	6	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANK3 ABI3BP SYNE1 TIAM2 FAT1 MCTP2	3.98e-05	199	140	6	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NIBAN1 CHD9 ITPRID2 HP1BP3 PTPRZ1 TPD52	3.98e-05	199	140	6	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NIBAN1 CHD9 ITPRID2 HP1BP3 PTPRZ1 TPD52	3.98e-05	199	140	6	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	TPR ATRX NSRP1 EVI5 BPTF BRD4	3.98e-05	199	140	6	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ATRX ITPRID2 BIRC6 FAM13B BPTF PINX1	4.10e-05	200	140	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PDE3A AFF2 ABI3BP SYNE1 FAT1 MCTP2	4.10e-05	200	140	6	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	CACNB2 ABI3BP SYNE1 FAT1 VCAN DMP1	4.10e-05	200	140	6	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	MYT1L BDP1 ANK3 RUNDC3B SYNE1 ANKRD36	4.10e-05	200	140	6	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer\|World / Primary Cells by Cluster	MYT1L BDP1 HIVEP2 ANK2 ANK3 RUNDC3B	4.10e-05	200	140	6	db10f76938af553d1a2275bb02ef75dff3c3135b
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CACNB2 ANK3 ABI3BP SYNE1 FAT1 DMP1	4.10e-05	200	140	6	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21\|World / Primary Cells by Cluster	MYT1L BDP1 HIVEP2 ANK2 ANK3 RUNDC3B	4.10e-05	200	140	6	30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc
ToppCell	COVID-19_Mild-Neu_0\|World / 5 Neutrophil clusters in COVID-19 patients	MARCHF10 ANK2 FAT1 TENM4 FAM186A	8.08e-05	140	140	5	93f024473b1bb3bf93ae776fd6a8fc5e93d013f0
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	HIVEP2 ANK3 PARP8 ANKRD36C ANKRD36	1.34e-04	156	140	5	1545169694f686d28648a68b552c2ae606599d66
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MYT1L DENND2B PPP1R26 MINDY4 MCTP2	1.39e-04	157	140	5	432b8719a8afd289cf48068e12c26a349d753fcc
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	MYT1L SGSM1 ANK2 ANK3 RUNDC3B	1.75e-04	165	140	5	9795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	CACNB2 PDE3A ANK2 COL18A1 TENM4	1.85e-04	167	140	5	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	CV-Mild-6\|CV / Virus stimulation, Condition and Cluster	SLK URI1 NLRP2 C2CD2L MCTP2	1.85e-04	167	140	5	cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf
ToppCell	390C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PDE3A ZGRF1 NLRP2 COL18A1 MLPH	2.12e-04	172	140	5	84d16cd7f618c94888920680bdc9e7130d73fd75
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 ATRX ATAD2 FAM13B CLSPN	2.18e-04	173	140	5	a5172dee859bf6c2eed46c48bd64dfef0ff9f28f
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 ATRX ATAD2 FAM13B CLSPN	2.18e-04	173	140	5	639b5b0b33ce5aa0bc26363c059717012ddc14c0
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SAAL1 AXDND1 CLSPN MLPH ZHX1	2.18e-04	173	140	5	12f779b8dce79431b2d1002ba524dd3f9566aeb0
ToppCell	TCGA-Brain-Primary_Tumor\|TCGA-Brain / Sample_Type by Project: Shred V9	DTNA CCDC160 PTPRZ1 TOR1AIP1 ZHX1	2.18e-04	173	140	5	f6ba22661e67c17d49d1058d4170ba8f36bf47f0
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SH3TC2 CCDC160 COL18A1 PTPRZ1 FAM186A	2.18e-04	173	140	5	789ab8b2709f4b8728e3733bc72744e9d92ea5ea
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNB2 ANK2 DTNA SYNE1 TENM4	2.29e-04	175	140	5	1d8aab491dcc27ea5dbfb6462d18ee280b21a05e
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNB2 ANK2 DTNA SYNE1 TENM4	2.29e-04	175	140	5	427a7ee92fe16a90625946492062d37aa0f7235b
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NIBAN1 PDE3A ANK2 DTNA XIRP2	2.36e-04	176	140	5	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SASH1 SYNE1 HIPK2 FAT1 MCTP2	2.36e-04	176	140	5	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 NIBAN1 PDE3A AFF2 DENND2B	2.42e-04	177	140	5	a8625d14682183cf77cb51eaf11bc15a3528f586
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 NIBAN1 PDE3A AFF2 DENND2B	2.42e-04	177	140	5	3645e2f4a48283f290f85c49c3e79e3f58ac9aa6
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	SYNE1 HIPK2 PPP1R26 KIF13A USP47	2.42e-04	177	140	5	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 PPP1R26 COL18A1 PTPRZ1 MLPH	2.48e-04	178	140	5	3e8aacb27ed1a3c3978e21dddddd0828f8000692
Computational	Genes upregulated in subsets of cells of a given type within various tumors	SYNE1 ANKRD36C BPTF FAT1 ZKSCAN1 ZNF638	2.64e-06	50	86	6	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Computational	Neighborhood of REV3L	TPR ATRX TTLL5 CHD9 FRYL	9.57e-05	58	86	5	MORF_REV3L
Computational	Neighborhood of ATRX	TPR CACNB2 GCFC2 ATRX DTNA TTLL5 CHD9 FRYL	3.13e-04	215	86	8	MORF_ATRX
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 ATRX SYNE1 BPTF	6.15e-04	49	86	4	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 SLK ATAD2 ZNF638	6.65e-04	50	86	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Drug	Clorgyline	BDP1 CACNB2 SLK ZNF280D ATRX ZFYVE16 CHD9 NSRP1 ZNF638 SENP7	8.59e-08	168	139	10	ctd:D003010
Drug	Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A	ZNF821 CACNB2 AFF2 DTNA HP1BP3 EVI5 ZFYVE9 PML	2.61e-05	194	139	8	5498_UP
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	TTLL5 ACAD10 EVI5 DNAJC17 ZFYVE9 CABIN1 BRF2 PML	2.71e-05	195	139	8	1144_DN
Drug	Prednisone [53-03-2]; Up 200; 11.2uM; HL60; HG-U133A	SLK GCFC2 KIAA0232 CHD9 CREB1 HP1BP3 EVI5 EDEM3	2.81e-05	196	139	8	1978_UP
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; PC3; HT_HG-U133A	GCFC2 ZFYVE16 ACAD10 BPTF BRD4 CABIN1 MCTP2 PML	2.92e-05	197	139	8	2126_DN
Drug	Ioversol [87771-40-2]; Up 200; 5uM; PC3; HT_HG-U133A	DTNA PARP8 HIPK3 VCAN DMP1 CABIN1 SENP7 BRF2	2.92e-05	197	139	8	6726_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A	ATN1 ANK3 TTLL5 DYSF HP1BP3 NCOR1 PML AHNAK2	3.02e-05	198	139	8	1648_UP
Drug	Cefotetan [69712-56-7]; Down 200; 7uM; MCF7; HT_HG-U133A	ZNF821 ATN1 RUNDC3B ITPRID2 DYSF EVI5 CABIN1 PML	3.02e-05	198	139	8	4116_DN
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	NIBAN1 ATN1 SASH1 SYNE1 TTLL5 TSC22D2 EDEM3 KIF13A	3.02e-05	198	139	8	7519_DN
Drug	Prednisolone [50-24-8]; Up 200; 11uM; MCF7; HT_HG-U133A	CACNB2 AFF2 DTNA PARP8 HIPK2 TEX14 HP1BP3 VCAN	3.13e-05	199	139	8	5526_UP
Drug	Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; HL60; HT_HG-U133A	ANK2 SYNE1 TTLL5 ACAD10 TULP3 DNAJC17 CABIN1 PML	3.13e-05	199	139	8	1280_DN
Drug	Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; HL60; HG-U133A	TPR SASH1 FRYL NCOR1 ZFYVE9 UBXN7 CABIN1 MLPH	3.25e-05	200	139	8	1592_DN
Disease	3-(3-amino-3-carboxypropyl)uridine measurement	ATAD2 ZHX1	2.11e-05	2	136	2	EFO_0800632
Disease	white matter microstructure measurement	CACNB2 SLK SASH1 SRGAP2 DYSF NSRP1 BPTF AXDND1 VCAN	8.59e-05	390	136	9	EFO_0005674
Disease	Glioblastoma Multiforme	ATRX NCOR1 FAT1 BRD4 PML	1.67e-04	111	136	5	C1621958
Disease	cerebrospinal fluid biomarker measurement, monocyte chemotactic protein 1 measurement	NIBAN1 EDEM3	3.13e-04	6	136	2	EFO_0006794, EFO_0010596
Disease	intellectual disability (implicated_via_orthology)	HIVEP2 ANK2 ZNF280D ATRX	4.07e-04	75	136	4	DOID:1059 (implicated_via_orthology)
Disease	Glioblastoma	NCOR1 FAT1 BRD4 PML	4.96e-04	79	136	4	C0017636
Disease	thyroxine measurement	ZGRF1 FNBP4 NCOR1 PWWP3B	5.98e-04	83	136	4	EFO_0005130
Disease	Giant Cell Glioblastoma	NCOR1 FAT1 BRD4 PML	6.26e-04	84	136	4	C0334588
Disease	Headache, glucose measurement	SGSM1 ZNF638	7.43e-04	9	136	2	EFO_0004468, HP_0002315
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	CACNB2 ANK3 SYNE1 TENM4	1.25e-03	101	136	4	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	ocular hypertension, response to triamcinolone acetonide	GCFC2 CHD9 TEX14	1.51e-03	49	136	3	EFO_0006954, EFO_1001069
Disease	heart failure	CACNB2 ACAD10 DYSF BPTF ZNF638	1.70e-03	185	136	5	EFO_0003144
Disease	Alopecia, Male Pattern	BRD4 HR	2.13e-03	15	136	2	C4083212
Disease	3-hydroxyanthranilic acid measurement	CCPG1 CREG2	2.13e-03	15	136	2	EFO_0010447
Disease	Androgenetic Alopecia	BRD4 HR	2.13e-03	15	136	2	C0162311
Disease	Female pattern alopecia (disorder)	BRD4 HR	2.13e-03	15	136	2	C0263477
Disease	Alzheimer's disease (implicated_via_orthology)	HIVEP2 PSEN1 ANK2	2.34e-03	57	136	3	DOID:10652 (implicated_via_orthology)
Disease	muscular dystrophy (is_implicated_in)	SYNE1 DYSF	2.74e-03	17	136	2	DOID:9884 (is_implicated_in)
Disease	retinal vasculature measurement	PDE3A TTLL5 HIPK2 DYSF DENND2B ZKSCAN1 XIRP2 PINX1	2.81e-03	517	136	8	EFO_0010554
Disease	systolic blood pressure, alcohol drinking	CACNB2 PDE3A ACAD10 PINX1	2.96e-03	128	136	4	EFO_0004329, EFO_0006335
Disease	fish consumption measurement	ACAD10 CREB1 TENM4	3.25e-03	64	136	3	EFO_0010139
Disease	Pseudopelade	BRD4 HR	3.43e-03	19	136	2	C0086873
Disease	Alopecia	BRD4 HR	3.43e-03	19	136	2	C0002170
Disease	serum gamma-glutamyl transferase measurement	SGSM1 PSEN1 ATRX CHD9 DENND2B BPTF ZZZ3 TENM4 PTCD1 PINX1 CABIN1	3.45e-03	914	136	11	EFO_0004532
Disease	bipolar I disorder	CACNB2 ANK3 SYNE1 TENM4	4.19e-03	141	136	4	EFO_0009963

Protein segments in the cluster

Peptide	Gene	Start	Entry
AERETETSNSESKQD	ZNF280D	761	Q6N043
SDTERSQKDAQTVEE	BDP1	426	A6H8Y1
TNLVEESSTEEDLSE	CABS1	331	Q96KC9
EEEEEQSECQTSVGT	BIRC6	4421	Q9NR09
EEEEECANATDVTTT	VCAN	1391	P13611
SDSSTDDSEEERAQR	BRD4	496	O60885
IETDSSTSDSNTDQE	AFF2	711	P51816
GRSEEISESESEETN	ATN1	71	P54259
SSDATNIEASIREED	ACAD10	801	Q6JQN1
ATTDEEDSVSNIATE	ANKRD36	691	A6QL64
TTDEEDSVSNIATEI	ANKRD36	726	A6QL64
DTEETQDTSVDHNET	ATAD2	1201	Q6PL18
IETASLRDENSESES	DENND2B	641	P78524
ENSSDTVSIQDSSEE	BPTF	1416	Q12830
DVESSSEEEDVTTCT	CERS5	351	Q8N5B7
AVTNEVDEELDSAST	CREG2	41	Q8IUH2
RQETFDSETQESRDS	CACNB2	551	Q08289
SEESVSTVEEQENET	HP1BP3	71	Q5SSJ5
DDETSVSESLQREAA	NSRP1	36	Q9H0G5
EREQEIVSDDESSSA	ANK2	3496	Q01484
TTDEEDSVSNIATEI	ANKRD36C	726	Q5JPF3
STTDADSEEINRQVT	FAT1	2941	Q14517
VSSSENDEDVLVTTE	PARP8	66	Q8N3A8
EQLDTNDESDVTSTL	LRRC37A3	1106	O60309
SVITISSDTDEEEEQ	HIPK2	886	Q9H2X6
SIQDSQESTDIDDEE	MCTP2	731	Q6DN12
QTTTERDSDTDVEEE	MDC1	446	Q14676
EERAQAIIDTTDDST	MAGEC1	1111	O60732
TESQEEETTENSTLE	GPR158	836	Q5T848
SIDVTNESRNDDDDT	ERVMER34-1	161	Q9H9K5
STNETTVENLESDVQ	KIAA2026	956	Q5HYC2
SSSSQEVDLVDQESS	EDEM3	821	Q9BZQ6
SSLENSESDVEENQE	FAM13B	811	Q9NYF5
TSESQISVNVEDCED	KCNT1	1031	Q5JUK3
SSSTSETSEEEVQDR	DCAF8L2	611	P0C7V8
LQQEEDTATNSSSEE	HR	526	O43593
NRQDTSDLTSEAVEE	KIAA0232	426	Q92628
ESTTDENEDDIQFVS	KIAA1586	21	Q9HCI6
ESDTEQLQDDDIETT	NUP85	616	Q9BW27
SDSSDIVQNEDETEC	PDE3A	631	Q14432
EENETTTTSAFTIQE	PINX1	166	Q96BK5
TEDSRSEEVEEQTTV	COL18A1	706	P39060
SESETEDSVLETRES	EVI5	776	O60447
SDEEEVQVDTALATS	DTNBP1	321	Q96EV8
TSLISTTEDINQEEE	FRYL	2396	O94915
NEEETSVDTSQENQE	GANC	176	Q8TET4
EDENSSDVELDTLSQ	NCBP3	221	Q53F19
VTASESDAEVERSQD	NLRP2	666	Q9NX02
SDSECETEETSTQEQ	NOL8	801	Q76FK4
SEEDNRVTSVSSDSQ	PTPRZ1	1481	P23471
SEEESAETTKETENN	DDX18	136	Q9NVP1
DSAQDTTSESRELDN	DMP1	156	Q13316
SQDQLTDEEEEDTVS	OSBPL1A	341	Q9BXW6
TISSDTDEEETSQRH	HIPK3	871	Q9H422
ASETEDLSTEATTQD	ITPRID2	36	P28290
ETETSQSSTVDSQDE	ERVK-6	871	Q9BXR3
QEDSSSENKSNSEEE	ATRX	1431	P46100
SDSDEEEAQKRESTT	CHD9	2196	Q3L8U1
DEESVASLSTTQDET	CHD9	2216	Q3L8U1
SASESEDRLVAEQET	CCPG1	186	Q9ULG6
EVLETSSQESSLESE	CABIN1	2196	Q9Y6J0
SVQEADETTRSDISE	C2CD2L	596	O14523
SISRNEETSEESQED	GCFC2	206	P16383
EQQEEEEVRSAENSS	AXDND1	991	Q5T1B0
SNVDVTTEESFNSTE	CCDC160	101	A6NGH7
SDEEESTSRNTSLSE	ANK3	4026	Q12955
STVTGDENISDSEIE	BRF2	376	Q9HAW0
VQISTIAESEDSQES	CREB1	86	P16220
IAESEDSQESVDSVT	CREB1	91	P16220
DSQESVDSVTDSQKR	CREB1	96	P16220
QAQAQESEEEEESRS	DNAJC17	106	Q9NVM6
SLNSRRESDDTEEET	MARCHF10	281	Q8NA82
EAVESTSQVDENDVT	CEP192	666	Q8TEP8
SSTVTEDFSEDSEVQ	DGKD	461	Q16760
SETESNVDSEFARTQ	DTNA	641	Q9Y4J8
ENQNTDSESSSEDVE	DCAF8L1	66	A6NGE4
SSTSDTSEEEGQDRV	DCAF8L1	581	A6NGE4
SEVSDTSEETQILRD	FAM186A	1991	A6NE01
ETSETTEINTDLARE	DNAH2	3591	Q9P225
ENSAESNTEETKRTD	SAAL1	371	Q96ER3
SNTEETKRTDLTQDD	SAAL1	376	Q96ER3
EVQETSRILDESEDT	DYSF	1291	O75923
RSQSESSDEVTELDL	C2CD5	656	Q86YS7
ELTSNVSDQETSSEE	MLPH	391	Q9BV36
VTASEVQQAESEVSD	MLPH	471	Q9BV36
ERVVEDDSSENSSES	KIF13A	836	Q9H1H9
SSEIEDEDQILENSS	FAN1	196	Q9Y2M0
LENQVEERTCSDSED	RIOK1	486	Q9BRS2
QSSDSISSDEEELRT	RUNDC3B	226	Q96NL0
RTEETSKETSESQDS	MRPS31	76	Q92665
RETTNENESTSESAL	SENP7	466	Q9BQF6
TATSNTEENDIDEET	TRIM37	541	O94972
TTSSEEEKEDRNTNV	URI1	241	O94763
STSQNSSVLHEEEDE	RNF157	436	Q96PX1
TTEGEEITESSSTEE	SLK	636	Q9H2G2
VRSTEDEQEETSKES	TEX14	1151	Q8IWB6
NAESTERESQDTVAE	PSEN1	316	P49768
EEEIQSLEESESSLS	SYNE1	3701	Q8NF91
QVATSITEDTESLDD	TSC22D2	21	O75157
DNSSSSEEDRESTAQ	FNBP4	961	Q8N3X1
TNLSQASTSDEEEIT	PWWP3B	101	Q5H9M0
QDVSDLTTVEREDSS	TAF11	61	Q15544
VVVISSSEDSDAENS	PML	556	P29590
SVASTVSAQEDEDIE	NCOR1	701	O75376
EDESVETQVNDSISA	NCOR1	776	O75376
ESQTDIEITREEDFT	CCT3	251	P49368
SRQSSSSEDSSLEEE	SH3TC2	416	Q8TF17
SSVDSDDSIEQEIRT	PPP1R26	526	Q5T8A7
DTEDDSEAEQTERNI	HERC2P3	671	Q9BVR0
ENSEESRVESTADDL	RIOX1	61	Q9H6W3
SSIQQVNVTDSDEEE	SOX30	731	O94993
EEERSGSQTESEEES	BRMS1	31	Q9HCU9
TSTDTEAQLTVERQE	AHNAK2	296	Q8IVF2
VLQDSDSETEDTNAS	CLSPN	61	Q9HAW4
SDVEETESKTEQTRD	XIRP2	896	A4UGR9
ESTTDENEDDIQFVS	ZNF451	21	Q9Y4E5
ESSQENKTVSEAESR	TVP23C	111	Q96ET8
SSEEDEASSQTDLSQ	TOR1AIP1	156	Q5JTV8
TNTENIETSTETAES	TIAM2	471	Q8IVF5
TIDTTQTISEDTDND	MINDY4	716	Q4G0A6
SETLSNEVFQESEEE	NIBAN1	611	Q9BZQ8
VTANEEINVTSTDSE	RNF111	311	Q6ZNA4
QVQSEITSANTEDDD	RNF34	211	Q969K3
TREEEEDSTIEASDQ	TPR	1831	P12270
ETTSVEDSTQDVTAE	SRGAP2	706	O75044
EERSDSDVNNDRSTS	USP47	941	Q96K76
NNDSSTTIIIDSSDE	ZHX1	531	Q9UKY1
NLTLTDTEHENTETD	TENM4	151	Q6N022
NCNSREQSDDETEES	SASH1	241	O94885
VDDRQSSEATTSQDE	SGSM1	811	Q2NKQ1
NFETSDTEEESQESN	ZGRF1	536	Q86YA3
TQTKQDSRSDEESES	UBXN7	306	O94888
SQDSTVSQEENSKED	ZNF483	141	Q8TF39
DEEETTQDEVSSHTS	ZNF821	61	O75541
ESSQENKTVSEAESR	TVP23B	111	Q9NYZ1
RNENEESTSKAETSE	ZKSCAN1	271	P17029
SSATLITNEDNEETE	WDR24	516	Q96S15
SATETLSEEEQEELR	TPD52	66	P55327
SHSNSTATQEEDEEE	PTCD1	71	O75127
EELQTTLEETDQSTQ	ABI3BP	616	Q7Z7G0
SEDSLNATEREQEEN	HIVEP2	2311	P31629
ETQSSLRDSEEEVDV	ZZZ3	306	Q8IYH5
SVVVTLNDSDDSESD	ZFC3H1	706	O60293
SVVEEDAENTVDTAS	TULP3	106	O75386
STLVTVDEIQDDSSD	ZNF638	1731	Q14966
LDEFEQNEDETVSST	ZFYVE9	16	O95405
ETASSSEDEEVISQE	TTLL5	11	Q6EMB2
DSDTVREQQNDISSE	ZFYVE16	181	Q7Z3T8
ISDEDTVDISNEASV	nan	126	Q8N402
GLEEEEEQTSEQDST	L1TD1	431	Q5T7N2
DTTSVNSDRSEEVFD	MYT1L	411	Q9UL68